Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Surveillance for cancers associated with tobacco use--United States, 1999-2004.

Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, Thompson TD, Weir HK, Sabatino SA; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2008 Sep 5;57(8):1-33.

2.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
3.

Epidemiology of cancer among Hispanics in the United States.

Trapido EJ, Burciaga Valdez R, Obeso JL, Strickman-Stein N, Rotger A, PĂ©rez-Stable EJ.

J Natl Cancer Inst Monogr. 1995;(18):17-28. Review.

PMID:
8562218
5.

Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.

Park S, Jee SH, Shin HR, Park EH, Shin A, Jung KW, Hwang SS, Cha ES, Yun YH, Park SK, Boniol M, Boffetta P.

BMC Cancer. 2014 Jun 6;14:406. doi: 10.1186/1471-2407-14-406. Review.

6.

Cancer control in Bangladesh.

Hussain SA, Sullivan R.

Jpn J Clin Oncol. 2013 Dec;43(12):1159-69. doi: 10.1093/jjco/hyt140. Epub 2013 Oct 25. Review.

7.

Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview.

Scosyrev E, Messing J, Noyes K, Veazie P, Messing E.

Urol Oncol. 2012 Mar-Apr;30(2):126-32. doi: 10.1016/j.urolonc.2009.11.005. Epub 2010 Apr 3. Review.

PMID:
20363162
8.

An Ecological Analysis of Tobacco Use and Oral Cavity and Pharynx Cancers in U.S. Males.

Damphousse KE, Mowls DS, Beebe LA.

J Okla State Med Assoc. 2015 Nov;108(11):488-91. Review.

PMID:
26817067
9.
10.

The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today.

Doll R, Peto R.

J Natl Cancer Inst. 1981 Jun;66(6):1191-308. Review.

PMID:
7017215
11.

The potential and limitations of data from population-based state cancer registries.

Izquierdo JN, Schoenbach VJ.

Am J Public Health. 2000 May;90(5):695-8. Review.

12.

Slowing the Titanic: China's Epic Struggle with Tobacco.

Stone EC, Zhou C; International Association for the Study of Lung Cancer Tobacco Control Committee.

J Thorac Oncol. 2016 Dec;11(12):2053-2065. doi: 10.1016/j.jtho.2016.07.020. Epub 2016 Aug 4. Review.

13.

The health consequences of smoking. Cancer.

Newcomb PA, Carbone PP.

Med Clin North Am. 1992 Mar;76(2):305-31. Review.

PMID:
1548964
14.

Cancer treatment and survivorship statistics, 2014.

DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A.

CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71. doi: 10.3322/caac.21235. Epub 2014 Jun 1. Review.

15.

The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.

Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME.

Am J Surg Pathol. 2016 Dec;40(12):e94-e102. Review.

16.

Cancer burden in Africa and opportunities for prevention.

Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM.

Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17. Review.

17.

Role of epidemiology in health risk assessment.

Krewski D, Wigle D, Clayson DB, Howe GR.

Recent Results Cancer Res. 1990;120:1-24. Review.

PMID:
2236869
18.

Population-based trends in lung cancer incidence in women.

Egleston BL, Meireles SI, Flieder DB, Clapper ML.

Semin Oncol. 2009 Dec;36(6):506-15. doi: 10.1053/j.seminoncol.2009.09.003. Review.

19.

Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions.

Schottenfeld D, Beebe-Dimmer JL.

Annu Rev Public Health. 2005;26:37-60. Review.

PMID:
15760280
20.

Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.

Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB.

Curr Probl Cancer. 2012 Jul-Aug;36(4):191-9. doi: 10.1016/j.currproblcancer.2012.03.008. Epub 2012 Apr 10. Review. No abstract available.

PMID:
22495057

Supplemental Content

Support Center